HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
People

STAT+: Sanofi research priorities in flux as new CEO logs in

A gene therapy for deafness, all eyes on Erasca, and other biotech news from The Readout

By STAT News · Apr 23, 2026 · via STAT News
STAT+: Sanofi research priorities in flux as new CEO logs in

Image: STAT News

This is an aggregated industry headline. Read the full story at STAT News →

Tags
peopleformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from People
All People →
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
PeopleFiercePharma ↗
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be head…
May 18, 2026
UPDATED: After Makary departure, CDER chief Tracy Beth Høeg headed out at FDA
PeopleFierceBiotech ↗
UPDATED: After Makary departure, CDER chief Tracy Beth Høeg headed out at FDA
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator is heading …
May 17, 2026
Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
PeopleFiercePharma ↗
Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
Takeda's multiyear slim-down is expected to hit about 4,500 roles during the 2026 fiscal year, resulting in ab…
May 17, 2026